Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

Functional constipation and soiling in children.

BIBLIOGRAPHIC SOURCE(S)

  • University of Michigan Health System. Functional constipation and soiling in children. Ann Arbor (MI): University of Michigan Health System; 2008 Sep. 15 p. [15 references]

GUIDELINE STATUS

This is the current release of the guideline.

This guideline updates a previous version: University of Michigan Health System. Functional constipation and soiling in children. Ann Arbor (MI): University of Michigan Health System; 2003 Feb. 10 p.

BRIEF SUMMARY CONTENT

 
RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

Note from the National Guideline Clearinghouse (NGC): The following key points summarize the content of the guideline. Refer to the full text of the original guideline document for additional information, including detailed information on diagnosis and "red flag" signs and symptoms; dosing and possible side effects for infants and children; cost of medications; instructions on education and behavioral training; and dietary choices.

The levels of evidence [A-D] are defined at the end of the "Major Recommendations" field.

For overview of diagnosis and treatment for age < 1 year, see Table 1 and for age > 1 year see Table 2 in the original guideline document.

Diagnosis

Functional constipation often begins during late infant to toddler age. [C*] Inquiring at doctor visits about stool frequency, character, and painful stool passage may aide earlier diagnosis. [IC & D]

  • Symptoms and signs (Tables 3 and 4 in the original guideline document) are the best guides for accurate diagnosis. [IC & D]
  • Red Flags (Table 5 in the original guideline document) should be checked to exclude other disorders. [IC & D]

Treatment

Child and family adherence to treatment recommendations is a likely predictor of success. [IC & D]

  • Educate child and family (see Table 6 in the original guideline document). [IC & D]
  • Clean-out impaction if present – applies only to age > 1yr (see Table 7 in the original guideline document). [IB]
  • Diet modification to increase fiber and clear fluids (see Table 8 in the original guideline document). [IC & D]
  • Behavioral training initiated for age > 1 year (see Table 9 in the original guideline document). [IC & D]
  • Medication (see Table 10 in the original guideline document) often needed to achieve stool frequency ≥ 3 times per week. [IA]
  • Consider referral for additional evaluation-management if treatment failure within first month. [ID]
  • Wean from medications – if used – after about 6 months if stool frequency ≥ 3 per week. [ID]
  • Dietary and behavioral components should continue. [ID]

Definitions:

Levels of Evidence

  1. Randomized controlled trials
  2. Controlled trials, no randomization
  3. Observational trials
  4. Opinion of expert panel

Strength of Recommendation

I = Generally should be performed

II = May be reasonable to perform

III = Generally should not be performed

CLINICAL ALGORITHM(S)

None provided

EVIDENCE SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

When possible, conclusions were based on prospective randomized clinical trials. In the absence of randomized controlled trials, observational studies were considered. If none were available, expert option was used.

The type of evidence supporting the recommendations is specifically stated for each recommendation (see 'Major Recommendations' field).

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

  • University of Michigan Health System. Functional constipation and soiling in children. Ann Arbor (MI): University of Michigan Health System; 2008 Sep. 15 p. [15 references]

ADAPTATION

Not applicable: The guideline was not adapted from another source.

DATE RELEASED

1997 Sep (revised 2008 Sep)

GUIDELINE DEVELOPER(S)

University of Michigan Health System - Academic Institution

SOURCE(S) OF FUNDING

University of Michigan Health System

GUIDELINE COMMITTEE

Functional Constipation and Soiling in Children Guideline Team

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Team Leader: Barbara T. Felt, MD, Developmental-Behavioral Pediatrics

Team Members: Pamela I. Brown, MD, Pediatric Gastroenterology; R. Van Harrison, PhD, Medical Education; Paramjeet K. Kochhar, MD, General Pediatrics; Susana R. Patton, PhD, Pediatric Psychology

Consultants: Sheila M. Marcus, MD, Psychiatry; Daniel H. Teitelbaum, MD, Pediatric Surgery

Guidelines Oversight Team: William E Chavey, MD; R Van Harrison, PhD; Connie J. Standiford, MD

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

Neither the members of the guideline team nor the consultant have a relationship with commercial companies whose products are discussed in this guideline.

GUIDELINE STATUS

This is the current release of the guideline.

This guideline updates a previous version: University of Michigan Health System. Functional constipation and soiling in children. Ann Arbor (MI): University of Michigan Health System; 2003 Feb. 10 p.

GUIDELINE AVAILABILITY

AVAILABILITY OF COMPANION DOCUMENTS

PATIENT RESOURCES

The following is available:

  • Functional constipation and soiling in children. Patient education handout. University of Michigan Health System; 2008 Sep. Various p.

Electronic copies: Available in English and Spanish from the University of Michigan Health System Web site. This resource also includes a bowel movement monitoring sheet and fiber content information.

Please note: This patient information is intended to provide health professionals with information to share with their patients to help them better understand their health and their diagnosed disorders. By providing access to this patient information, it is not the intention of NGC to provide specific medical advice for particular patients. Rather we urge patients and their representatives to review this material and then to consult with a licensed health professional for evaluation of treatment options suitable for them as well as for diagnosis and answers to their personal medical questions. This patient information has been derived and prepared from a guideline for health care professionals included on NGC by the authors or publishers of that original guideline. The patient information is not reviewed by NGC to establish whether or not it accurately reflects the original guideline's content.

NGC STATUS

This summary was completed by ECRI on May 20, 1999. The information was verified by the guideline developer on June 17, 1999. This NGC summary was updated by ECRI on January 19, 2004. The updated information was verified by the guideline developer on February 6, 2004. This NGC summary was updated by ECRI Institute on March 19, 2009. The updated information was verified by the guideline developer on April 8, 2009.

COPYRIGHT STATEMENT

This NGC summary is based on the original guideline, which is copyrighted by the University of Michigan Health System (UMHS).

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo